Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Andreas Faldum et al.|Clinical Cancer Research|2014Cited by 99
Characterization of Rearrangements Involving the <i>ALK</i> Gene Reveals a Novel Truncated Form Associated with Tumor Aggressiveness in NeuroblastomaAlex Cazes, Isabelle Janoueix‐Lerosey|Cancer Research|2012Cited by 66
Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0